SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Acurex Biosciences Receives U.S. Patent for CU-00048

The patent protects CU-00048 into 2042. The company describes the drug candidate as a potential T-type calcium channel antagonist for essential tremor.

Related stories